Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for interferon α treatment of chronic hepatitis C

Cytokine

Volumn 8, Issue 4, 1996, Pages 318-322

  Carreño, Vicente ^a,b   Parra, Adolfo ^a,c   Navas, Sonia ^a   Quiroga, Juan Antonio ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Hepatology Unit   (Spain)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; Granulocyte macrophage colony stimulating factor; IFN ; Therapeutic application

Indexed keywords

ALPHA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VIRUS RNA;

ADJUVANT THERAPY; ADULT; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOPOTENTIATION; INFLAMMATION; INFLUENZA; LEUKOCYTE; MALE; NAUSEA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

EID: 0029927669     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0043     Document Type: Article

References (16)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, and the Hepatitis Interventional Therapy Group (1989) Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 321:1501-1506.
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989) Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1510.
3. Shindo M, Di Bisceglie AM, Cheung L, Shih JWK, Cristiano K, Feinstone S, Hoofnagle JH (1991) Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 115:700-704.
4. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (part I). N Engl J Med 327:28-35.
5. Martin J, Bosch O, Moraleda G, Bartolomé J, Quiroga JA, Carreño V (1993) Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. Hepatology 18:775-780.
6. Gurakar A, Fagiuoli S, Gavaler JS, Hassanein T, Jabbour N, Wright HI, Deal SA, Shah A, Brown M, Carr BI, Van Thiel DH (1994) The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenism. J Hepatol 21:582-586.
7. Pardo M, Castillo I, Navas S, Carreño V (1995) Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha. J Med Virol 45:439-444.
8. Martin J, Quiroga JA, Bosch O, Carreño V (1994) Changes in cytokine production during therapy with granulocyte-macrophage colony-stimulating factor in chronic hepatitis B. Hepatology 20:1156-1161.
9. Negro F, Baldi M, Mondardini A, Leandro G, Chaneac M, Manzini P, Abate ML, Zahm F, Dastoli G, Ballaré M, Ryff JC, Verme G, Bonino F (1994) Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a. Gastroenterology 107:479-485.
10. Rumi MG, Romeo R, Colombo M (1994) Predictors of alpha interferon response in patients with chronic hepatitis C. In Nishioka K, Suzuki H, Mishiro S, Oda T (eds) Viral hepatitis and liver disease, Springer-Verlag, Tokyo pp 614-616.
11. Yoshioka K, Kamuku S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T (1992) Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16:293-299.
12. Perrillo RP (1995) Chronic hepatitis B: problem patients (including patients with decompensated disease). J Hepatol 22(suppl.1):45-48.
13. Silva M, Pérez V, Manero E, Escoms S, Tanno H, Bariletto S, Albrecht J (1994) GM-CSF plus interferon in chronic hepatitis B patients who failed previous interferon therapy (abstract 813). In Program and Abstracts of the 45th Annual Meeting of the American Association for the Study of Liver Diseases (Chicago). Hepatology 20:300A.
14. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
15. Castillo I, Bartolomé J, Navas S, González S, Herrero M, Carreño V (1994) Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon. Hepatology 19:1342-1346.
16. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakama Y, Mayumi M (1992) Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679.